The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels

Regul Pept. 1992 Sep 3;41(1):9-18. doi: 10.1016/0167-0115(92)90509-s.

Abstract

Endothelium-independent vasoconstrictor responses in isolated segments of human internal thoracic artery (ITA) and saphenous vein (SV) were used as a bioassay system for the vasoinhibitory activity of bovine chromogranin A (CGA). Preincubation with vasostatin (0.8 micrograms/ml), containing the N-terminal domain of CGA, (CGA1-76, CGA1-113 and CGA1-143ff), inhibited the contractile responses evoked by 80 mM K+, 2.6 microM noradrenaline (NA), or 65 nM endothelin-1 (ET-1) in Ca(2+)-free solution in SV but not in ITA. The results demonstrate a vasoinhibitory activity in vasostatin and show that there is a marked difference between the arterial and venous segments in the Ca2+ independent component of the inhibitory response. A vascular role for the N-terminal domain of CGA is indicated, presumably by inhibiting Ca2+ release from intracellular stores in the human vein but not the artery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium / metabolism
  • Chromogranin A
  • Chromogranins / pharmacology*
  • Endothelins / pharmacology
  • Humans
  • In Vitro Techniques
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • Norepinephrine / pharmacology
  • Potassium / pharmacology
  • Saphenous Vein / drug effects*
  • Saphenous Vein / metabolism
  • Thoracic Arteries / drug effects*
  • Thoracic Arteries / metabolism
  • Vasoconstriction / drug effects*

Substances

  • CHGA protein, human
  • Chromogranin A
  • Chromogranins
  • Endothelins
  • Potassium
  • Calcium
  • Norepinephrine